Flex Pharma Demonstrates Single Agent Efficacy and Dose Response in Reducing Human Muscle Cramps
October 20, 2015 at 08:00 AM EDT
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for exercise-associated ...